Ravi Pamnani net worth
Quick answer
Ravi Pamnani's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Ravi Pamnani is CEO at Intact Therapeutics. Intact Therapeutics valuation.
Ravi Pamnani is CEO at Intact Therapeutics (YC W19). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 4
- Website: http://www.intacttherapeutics.com
Who is Ravi Pamnani?
Ravi Pamnani is a founder of Intact Therapeutics, which was part of Y Combinator's Winter 2019 batch.
Highlights:
- Stanford University
- MIT
- Part of Y Combinator W19
About Intact Therapeutics
Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.
FAQ: Ravi Pamnani net worth and Intact Therapeutics valuation
What is Ravi Pamnani's net worth?
Ravi Pamnani's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Ravi Pamnani is CEO at Intact Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Intact Therapeutics valuation?
Intact Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Ravi Pamnani's role?
Ravi Pamnani is CEO at Intact Therapeutics, a Y Combinator-backed startup (batch W19).